ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,984Medicare Part D Prescriptions Filled, Including Refills

Rank: 185 out of 1000

$783K Total Retail Price of All Prescriptions

Rank: 113 out of 1000

298 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 298 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

35% of this provider’s 298 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 11,746 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 537 490 S3 1 1
FUROSEMIDE 525 498 2 7
SIMVASTATIN 306 288 3 3
POTASSIUM CHLORIDE 292 286 4 10
LEVOTHYROXINE SODIUM 287 280 5 4
ESCITALOPRAM OXALATE 282 257 6 60
WARFARIN SODIUM 280 258 7 22
DONEPEZIL HCL 268 268 8 32
CARVEDILOL 243 219 9 15
OMEPRAZOLE 238 217 10 2
FAMOTIDINE 237 210 11 88
AMLODIPINE BESYLATE 231 204 12 6
QUETIAPINE FUMARATE 231 214 12 75
TRAMADOL HCL 228 199 14 13
LISINOPRIL 217 171 15 5
METFORMIN HCL 184 173 16 8
MIRTAZAPINE 175 168 17 56
LANTUS 172 151 18 68
METOPROLOL TARTRATE 167 167 19 19
TRAZODONE HCL 150 141 20 29
GABAPENTIN 139 129 21 11
DIVALPROEX SODIUM 132 105 22 113
NAMENDA 130 130 23 43
CITALOPRAM HBR 127 109 24 17
CLONIDINE HCL 126 106 25 27
SERTRALINE HCL 111 109 26 26
LEXAPRO 109 103 27 196
SEROQUEL 109 97 27 157
MELOXICAM 105 105 29 14
CYMBALTA 103 71 30 53
ZOLPIDEM TARTRATE 102 92 31 16
HALOPERIDOL 100 86 32 211
RESTASIS 96 64 33 272
DIGOXIN 95 89 34 52
SPIRIVA 94 86 35 64
FENTANYL 93 81 S2 36 100
GLIPIZIDE 91 91 37 62
METOPROLOL SUCCINATE 91 79 37 21
LOSARTAN POTASSIUM 90 89 39 25
AZITHROMYCIN 90 84 39 36
SYMBICORT 88 85 41 149
OXYBUTYNIN CHLORIDE ER 84 82 42 157
CEFTRIAXONE 78 75 43 213
PRAVASTATIN SODIUM 78 43 43 12
LANTUS SOLOSTAR 73 73 45 120
PROMETHAZINE HCL 72 67 R 46 54
RAMIPRIL 71 70 47 77
BENZTROPINE MESYLATE 70 59 R 48 180
LYRICA 70 51 48 47
ALENDRONATE SODIUM 69 60 50 57
TAMSULOSIN HCL 69 69 50 33
ATENOLOL 68 68 52 24
NITROFURANTOIN MONO-MACRO 66 66 53 191
ALBUTEROL SULFATE 65 65 54 142
ALLOPURINOL 65 52 54 31
CARBIDOPA-LEVODOPA 63 50 56 116
ROPINIROLE HCL 61 59 57 82
RISPERIDONE 60 42 58 87
NEXIUM 59 48 59 23
LATANOPROST 57 55 60 222
OLANZAPINE 57 56 60 188
AMIODARONE HCL 56 43 62 178
CLOPIDOGREL 54 54 63 35
LIDOCAINE HCL 54 52 63 236
NOVOLIN R 51 39 65 185
DIOVAN 51 51 65 67
PLAVIX 51 48 65 49
PANTOPRAZOLE SODIUM 50 50 68 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.